Similar Papers

Paper Title
Journal
Date
Author
Clinical Relevance of Cerebral Small Vessel Diseases.
Marco Pasi ... Charlotte Cordonnier
Stroke | VOL. 51
Marco Pasi, et. al.Marco Pasi ... Charlotte Cordonnier
22 Nov 2019
Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial.
...
Frontiers in pharmacology | VOL. 13
, et. al. ...
06 Jan 2023
Cerebral tau pathology in cerebral amyloid angiopathy.
Hsin-Hsi Tsai ... Chia-Ju Liu
Brain communications | VOL. 6
Hsin-Hsi Tsai, et. al.Hsin-Hsi Tsai ... Chia-Ju Liu
01 Mar 2024
Abstract TP458: Is There “Crosstalk” Between Intracranial Arterial Pathologies and Small Vessel Disease??
Gregoire Boulouis ... Yael D Reijmer
Stroke | VOL. 47
Gregoire Boulouis, et. al.Gregoire Boulouis ... Yael D Reijmer
01 Feb 2016
View more papers

More From: Stroke

Paper Title
Journal
Date
Author
Flipping the Script: Early Neurological Gains May Redefine Recovery Prognostication After Intracerebral Hemorrhage.
Miriam Quinlan ... Susanne Muehlschlegel
Stroke | VOL. -
Miriam Quinlan, et. al.Miriam Quinlan ... Susanne Muehlschlegel
03 Feb 2025
Subacute Neurological Improvement Predicts Favorable Functional Recovery After Intracerebral Hemorrhage: INTERACT2 Study.
Shoujiang You ...
Stroke | VOL. -
Shoujiang You, et. al.Shoujiang You ...
03 Feb 2025
Abstract TMP9: What Drives Early Recurrence in Intracranial Atherosclerosis: A Multicenter Study
Shadi Yaghi ... Karen Furie
Stroke | VOL. -
Shadi Yaghi, et. al.Shadi Yaghi ... Karen Furie
01 Feb 2025
Abstract WMP106: Stroke Risk and Urinary Albumin-to-Creatinine Ratio: A Post-Hoc Analysis of the ACCORD Trial
Yvonne Kim ... Adam De Havenon
Stroke | VOL. -
Yvonne Kim, et. al.Yvonne Kim ... Adam De Havenon
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.